Clinical Study to Reduce Premature Ejaculation in Healthy Adult Men
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age21-50
SponsorHerbolab India Pvt. Ltd.
About this trial
The current study focuses on clinical validation of efficacy of nutraceutical product in management of male health. In healthy adult men with induced premature ejaculation, the introduction of these nutraceuticals has been associated with notable improvements in quality of life. These supplements help them for enhanced sexual satisfaction, increased control over ejaculation, and a reduction in performance anxiety. The psychological benefits are significant, as the improvement in sexual function can lead to higher self-confidence and a more positive outlook on life.
Eligibility criteria
Qualifiers
Male participants aged 21-50 years both inclusive suffering from a. PE or b. ED
Suffering from self-reported mild to moderate stress on the PSS scale score less than or equal to 26
Participant having baseline IELT of less than 2 min
Participants meeting with diagnostic criteria for PEP score greater than or equal to 11
Disqualifiers
Previous events or other severe conditions that may affect premature ejaculation/erectile dysfunction, including but not limited to spinal trauma or pelvic surgery
Participants with genital anatomical deformities, including but not limited to penile deformities
Participants for whom sexual activity is inadvisable because of their underlying disease status
Female partners experiencing sexual dysfunction, such as painful intercourse, low libido, or other forms of sexual dysfunction, as well as pregnant individuals
Trial design
Treatments tested in this trial
- Destress and Perform Capsule-U001
- Destress and Perform Capsule-I001
- Placebo capsules 002
Treatment groups
60 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov